Advanced search
1 file | 399.61 KB

Malignant pleural mesothelioma: the standard of care and challenges for future management

Author
Organization
Keywords
Mesothelioma, Cancer, Pleura, Chemotherapy, Surgery, Radiotherapy, Palliation, Supportive care, Pleurodesis, PHASE-II TRIAL, MODULATED RADIATION-THERAPY, HISTONE DEACETYLASE INHIBITORS, PEMETREXED PLUS CARBOPLATIN, DOSE HEMITHORACIC RADIATION, RANDOMIZED CONTROLLED-TRIAL, ENDOTHELIAL GROWTH-FACTOR, EXTRAPLEURAL PNEUMONECTOMY, LUNG-CANCER, EUROPEAN-ORGANIZATION, Guidelines, Treatment

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 399.61 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Van Meerbeeck, Jan, Arnaud Scherpereel, Veerle Surmont, and Paul Baas. 2011. “Malignant Pleural Mesothelioma: The Standard of Care and Challenges for Future Management.” Critical Reviews in Oncology Hematology 78 (2): 92–111.
APA
Van Meerbeeck, J., Scherpereel, A., Surmont, V., & Baas, P. (2011). Malignant pleural mesothelioma: the standard of care and challenges for future management. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 78(2), 92–111.
Vancouver
1.
Van Meerbeeck J, Scherpereel A, Surmont V, Baas P. Malignant pleural mesothelioma: the standard of care and challenges for future management. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2011;78(2):92–111.
MLA
Van Meerbeeck, Jan, Arnaud Scherpereel, Veerle Surmont, et al. “Malignant Pleural Mesothelioma: The Standard of Care and Challenges for Future Management.” CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 78.2 (2011): 92–111. Print.
@article{2026914,
  author       = {Van Meerbeeck, Jan and Scherpereel, Arnaud and Surmont, Veerle and Baas, Paul},
  issn         = {1040-8428},
  journal      = {CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY},
  keywords     = {Mesothelioma,Cancer,Pleura,Chemotherapy,Surgery,Radiotherapy,Palliation,Supportive care,Pleurodesis,PHASE-II TRIAL,MODULATED RADIATION-THERAPY,HISTONE DEACETYLASE INHIBITORS,PEMETREXED PLUS CARBOPLATIN,DOSE HEMITHORACIC RADIATION,RANDOMIZED CONTROLLED-TRIAL,ENDOTHELIAL GROWTH-FACTOR,EXTRAPLEURAL PNEUMONECTOMY,LUNG-CANCER,EUROPEAN-ORGANIZATION,Guidelines,Treatment},
  language     = {eng},
  number       = {2},
  pages        = {92--111},
  title        = {Malignant pleural mesothelioma: the standard of care and challenges for future management},
  url          = {http://dx.doi.org/10.1016/j.critrevonc.2010.04.004},
  volume       = {78},
  year         = {2011},
}

Altmetric
View in Altmetric
Web of Science
Times cited: